Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hahn

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2019
The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?Felix Hahn, Lukas Müller, Fabian Stöhr, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2023
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimatesLukas Müller, Simon J Gairing, Friedrich Foerster, et al.
Plos One|May 7, 2021
The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort studyAline Mähringer-Kunz, Verena Steinle, Roman Kloeckner, et al.
Journal of Clinical Medicine|June 2, 2021
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk AssessmentLukas Müller, Aline Mähringer-Kunz, Simon Johannes Gairing, et al.
United European Gastroenterology Journal|June 2, 2021
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significanceAline Mähringer-Kunz, Franziska I Meyer, Felix Hahn, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 7, 2026
Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstructionMaximilian Moos, Tilman Emrich, Maximilian Nguyen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2022
Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?Lukas Müller, Felix Hahn, Florian Jungmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 17, 2020
Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot StudyAline Mähringer-Kunz, Franziska Wagner, Felix Hahn, et al.
Plos One|February 4, 2020
Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging systemFelix Hahn, Lukas Müller, Aline Mähringer-Kunz, et al.
Scientific Reports|July 17, 2024
Amount of ascites impacts survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization advocating for volumetric assessmentLukas Müller, Daniel Bender, Simon J Gairing, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2019
The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?Felix Hahn, Lukas Müller, Fabian Stöhr, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2023
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimatesLukas Müller, Simon J Gairing, Friedrich Foerster, et al.
Plos One|May 7, 2021
The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort studyAline Mähringer-Kunz, Verena Steinle, Roman Kloeckner, et al.
Journal of Clinical Medicine|June 2, 2021
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk AssessmentLukas Müller, Aline Mähringer-Kunz, Simon Johannes Gairing, et al.
United European Gastroenterology Journal|June 2, 2021
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significanceAline Mähringer-Kunz, Franziska I Meyer, Felix Hahn, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 7, 2026
Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstructionMaximilian Moos, Tilman Emrich, Maximilian Nguyen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2022
Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?Lukas Müller, Felix Hahn, Florian Jungmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 17, 2020
Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot StudyAline Mähringer-Kunz, Franziska Wagner, Felix Hahn, et al.
Plos One|February 4, 2020
Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging systemFelix Hahn, Lukas Müller, Aline Mähringer-Kunz, et al.
Scientific Reports|July 17, 2024
Amount of ascites impacts survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization advocating for volumetric assessmentLukas Müller, Daniel Bender, Simon J Gairing, et al.
Pageof 6